The AACR Gertrude B. Elion Cancer Research Award funds innovative cancer research by junior faculty worldwide in etiology, diagnosis, treatment, or prevention.
Funder: American Association for Cancer Research
Due Dates: June 4, 2026 (Letter of Intent, 1:00 PM ET) | September 16, 2026 (Full Application, 1:00 PM ET)
Funding Amounts: $225,000 for a one-year project; funds cover personnel, supplies, equipment, travel, and publication costs.
Summary: Supports tenure-eligible junior faculty worldwide in innovative cancer research spanning etiology, diagnosis, treatment, or prevention.
Key Information: Applicants must be AACR members in good standing by the LOI deadline and hold an eligible assistant professor appointment.
This award, supported by GlaxoSmithKline and administered by the American Association for Cancer Research (AACR), is designed to foster innovative research in cancer etiology, diagnosis, treatment, or prevention. It specifically targets tenure-eligible junior faculty and supports research projects that may be basic, translational, or clinical in nature. The grant provides funding for a wide range of research-related expenses, including personnel, supplies, equipment, travel, and publication costs, with the goal of helping early-career investigators establish independent research programs and advance the field of cancer research.